Ledger.Open graph →
SEC Form D · Amendment · filed December 31, 2024

Topo Therapeutics, Inc

Offering
$95.0M
Sold
$10.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

J. Geshwiler · Cambridge, MAExec · DirectorSolus Alternative Asset Management Lp · Summit, NJDirectorM. John Henry Oil Corporation · Knoxville, TNExec · DirectorJacob Stenziano · KNOXVILLE, TNExec · DirectorJonathan R. Levin · Chigaco, ILDirectorA. Gcm Cfig Gp, Llc · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗